Challenges in the Management of Breast and Thoracic Malignancies

October 5-7, 2017 Sheraton Seattle Hotel Seattle, WA

Register online SeattleCCA.org/cme

2 3

SeattleC

CA

.org/cme

Cou

rse

sum

mar

y Course descriptionThis 2.5-day symposium will provide up-to-date information to clinicians involved in the care of patients with breast or thoracic cancers. Speakers are nationally and internationally renowned clinicians and researchers who will share their expertise and foster discussion of the most recent multidisciplinary advances in screening, pathology, surgery, radiology, medical oncology, chemotherapy, immunotherapies, genetics and survivorship. Far-ranging areas of consensus and controversy will be presented and discussed with a goal that attendees leave with state-of-the-art knowledge of cancer care for breast and thoracic malignancies.

Learning objectivesUpon completion of this activity, attendees should be able to:

Thoracic portion (Thursday)

• Discuss the recent advances in thoracic surgery, radiation, and immunotherapy for treating lung cancer.

• Discuss the role for standard radiation and protons for thoracic malignancies disease.• Review the choice of options for early stage lung cancer.• Understand new options for small cell lung cancer.• Discuss the most current systemic therapies for stage IV NSCLC.• Review treatment options for thymic malignancies.• Understand advances in multimodality therapy for pleural mesothelioma.• Discuss value-based health care and the impact of payment reform.

Breast portion (Friday and half-day Saturday)

• Describe the pathogenesis, diagnostic evaluation and therapeutic advances for integration into the management of newly diagnosed breast cancer.

• Describe the therapeutic modalities available for advanced breast cancer, and neoadjuvant therapies in particular.

• Describe evidence-based recommendations for supportive care and survivorship.• Describe how cancer outcomes can vary in different populations and potential reasons why.• Discuss the impact of medical reform in the realm of oncology.• Discuss how to manage patients at high risk for breast cancer, especially screening, prevention,

and long-term surveillance.• Navigate and interpret the plethora of available genetic tests and possible results.• Discuss the ever-changing landscape of known genetic mutations.• Illustrate the controversy regarding DCIS as a pathologic diagnosis and whether or not it requires

local and/or systemic treatment. • Discuss the role of reconstruction for patients in treatment as well as post-treatment.

CME/CE credit designation statementThe University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 17.0 PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider #16496, for:

7.2 Contact Hours for the Thoracic Oncology portion

8.4 Contact Hours for the Breast Oncology portion

Registration feesThoracic portion only (Thursday)

Breast portion only (Friday and half-day Saturday

All Days

MD / PhD $300 $400 $525

UW / FH / SCCA Staff or SCCA Network Member*

$250 $350 $475

Allied Health Professionals (incl. NPs and PAs)

$225 $325 $425

Resident / Fellow $200 $300 $400

UW Resident / UW Fellow $175 $275 $375

The fee for this course includes catering, all instruction materials, and transcript of AMA PRA Category 1 Credits.™ To ensure enrollment, please register online (see Registration). If you are an SCCA employee please email cme@seattlecca.org to register. If you have not received written confirmation prior to your departure for the course, contact the SCCA Strategic Outreach and Affiliate Network Office at (206) 288-1066. The SCCA Strategic Outreach and Affiliate Network Office will not be responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the course. If you have any additional questions, please contact the SCCA Strategic Outreach and Affiliate Network Office at sccanet@seattlecca.org or (206) 288-1066.

*SCCA Network Member rate is for employees of SCCA Network Members. For a full list of Network Members please visit SeattleCCA.org/network-members.cfm.

Intended audienceThe course is designed for health care providers who treat patients with breast or thoracic cancer. Providers include surgeons, radiation, medical and surgical oncologists, pulmonologists, general practitioners, physicians assistants, oncology nurses, oncology pharmacists, fellows and other clinical trainees.

Additional course informationFor information about online conference materials, the attendance policy, cancellation policy and special services, please visit the conference website. For the link to the conference website, please visit www.seattlecca.org/cme.

Conference location and lodgingThe conference will be held in the heart of Seattle’s vibrant downtown at the Sheraton Seattle Hotel: 1400 Sixth Ave., Seattle, WA 98101.

Regarding lodging, Seattle Cancer Care Alliance has not contracted for any special conference rates and accepts no responsibility for lodging. You may contact Sheraton.com for onsite lodging or visitseattle.org for lodging ideas in the area.

Thoracic Portion Co-Presented by the American Lung Association’s LUNG FORCESee Page 8 for more information.

Register at SeattleCCA.org/cme

4 5

SeattleC

CA

.org/cme

Cou

rse

facu

lty

For full listing of the course faculty and their titles, please visit the conference website.

Course chairsThoracic Oncology Breast Oncology

Douglas Wood, MD, FACS, FRCSEdThe Henry N. Harkins Professor and Chair of the Department of Surgery

Renato Martins, MD, MPHMedical Director, Thoracic/Head and Neck Oncology

Shilpen Patel, MDAssociate Professor, Department of Radiation Oncology

Kristine E Calhoun, MDAssociate Professor, Department of Surgery

Janice Kim, MDAssociate Professor, Department of Radiation Oncology

VK Gadi, MD, PhD, Chair EmeritusAssociate Professor, Department of Oncology

Guest faculty Thoracic Oncology Breast Oncology

Karen Reckamp, MD, MSAssociate Professor, Medical Oncology, City of Hope, Duarte, CA

Anees B. Chagpar, MD, MBA, MPH, FACS, FRCS(C)Associate Professor of Surgery (Oncology); Assistant Director, Global Oncology, Yale Comprehensive Cancer Center, New Haven, CT

Charles E. Leonard, MD Radiation Oncologist, Rocky Mountain Cancer Centers, Littleton, CO

University of Washington, Fred Hutch and Seattle Cancer Care Alliance faculty

Thoracic Oncology Breast OncologyChristina Baik, MD, MPHKathleen Berfield, MDLaura QM Chow, MDKeith Eaton, MD, PhDFarhood Farjah, MD, MPHBernardo Goulart, MD, MSSylvia Lee, MDMike Mulligan, MDRamesh Rengan, MD, PhDRafael Santana-Davila, MD

Ben Anderson, MDCarol Baltaxe, PT, MPT, CLTRobin L. Bennett, MS, ScD HonDenise Bundow, ARNPDavid Byrd, MDJennie R Crews, MD, MMMNancy E Davidson, MDChristine Fang, MDLaura James, NDSara Javid, MDMark Kilgore, MDMary-Claire King, PhD

Diana L Lam, MD Janie Lee, MD, MScHannah Linden, MDBarbara S Norquist, MDSavannah Partridge, PHDHakim Said, MDJohn R Scheel, MD, PhDVeena Shankaran, MD, MSJanelle D Sousa, MDBeti Thompson, PhDRachel Yung, MD

Thursday, October 5, 2017 Thoracic Oncology

7:30 am Breakfast, Registration and Exhibits Open

8:00 am Welcome and Introductions

Therapy for Localized Lung Cancer

8:10 am When should localized lung cancer be treated with radiation rather than surgery?

Farhood Farjah, MD, MPH Shilpen Patel, MD

8:25 am Proton therapy for locally advanced lung cancer

Ramesh Rengan, MD, PhD

8:40 am Sublobar resection for lung cancer in the era of lung cancer screening

Kathleen Berfield, MD

8:55 am Extended resections for non-small cell lung cancer

Douglas Wood, MD, FACS, FRCSEd

9:10 am Discussion

Breakout 1 9:30 am

Choosing the right treatment form for early stage lung cancer

Mike Mulligan, MD Kathleen Berfield, MD Pablo Sanchez, MD, PhD Ramesh Rengan, MD, PhD

Advances in mesothelioma Farhood Farjah, MD, MPH Bernardo Goulart, MD, MS

Stage 3A Renato Martins, MD, MPH Shilpen Patel, MD Douglas Wood, MD, FACS, FRCSEd

10:30 am Break

Updates

10:45 am ASCO review 1 Karen Reckamp, MD, MS

11:00 am ASCO review 2 Christina Baik, MD, MPH

11:15 am Radiation and immune modulation Ramesh Rengan, MD, PhD

11:30 am Cellular immunotherapy for thoracic malignancies

Sylvia Lee, MD

11:45 am Discussion

12:05 pm Lunch

Afternoon Session

1:00 pm Immunotherapy in lung cancer Renato Martins, MD, MPH

1:15 pm Targeted therapy in lung cancer; beyond EGFR ALK and ROS-1

Karen Reckamp, MD, MS

1:30 pm Value in healthcare Keith Eaton, MD, PhD

1:45 pm Payment reform Shilpen Patel, MD

2:00 pm Discussion

Breakout 2 2:20 pm

Small cell lung cancer (finally something new)

Rafael Santana-Davila, MD Ramesh Rengan, MD, PhD

Management of immunotherapy toxicities

Laura QM Chow, MD

Thymic malignancies Farhood Farjah, MD, MPH Bernardo Goulart, MD, MS Shilpen Patel, MD

3:20 pm Break

3:45 pm Tumor board

4:50 pm-5:00 pm Closing; adjourn Thoracic portion

6 7

Cou

rse

sche

dule

SeattleC

CA

.org/cme

Friday, October 6, 2017Breast Oncology

7:30 am Breakfast, Registration and Exhibits Open

8:00 am Welcome and Introductions Kris Calhoun, MD

Management of the High Risk Patient

8:00 am Case Denise Bundow, ARNP

8:10 am Breast cancer screening in high risk patients

Diana L Lam, MD

8:30 am How to manage the plethora of new mutations

Robin Bennett, MS, LGC, PhD Hon

8:50 am Chemoprevention Rachel Yung, MD

9:10 am Surgical options for gynecologic cancer prevention

Barbara S Norquist, MD

9:30 am Tests out there Mary-Claire King, PhD

9:50 am Panel All

10:10 am Break

DCIS Management: Cancer or Not?

10:25 am Surgery and radiation: yes Anees Chagpar, MD, MBA, MPH

10:45 am Surgery and radiation: no Charles Leonard, MD

11:05 am Rebuttal: surgery and radiation All

11:25 am Panel All

11:45 am Lunch

Disparities (Special Talks)

12:45 pm Financial toxicity in cancer care Veena Shankaran, MD

1:05 pm Medical reform in oncology TBD

1:25 pm Health reform: What happens when the ACA disappears?

Beti Thompson, PhD

1:45 pm Health disparities in diverse populations

Hannah Linden, MD

2:05 pm Panel All

2:25 pm Break

Neoadjuvant

2:40 pm Case Janie Lee, MD, MSc

2:50 pm Pathology Mark Kilgore, MD

3:10 pm Imaging Savannah Partridge, PhD

3:30 pm Surgical: alliance trial David Byrd, MD

3:50 pm What to do with residual disease? Nancy Davidson, MD

4:10 pm Panel All

4:30 pm Closing; adjourn for the day Kris Calhoun, MD

Saturday, October 7, 2017Breast Oncology

7:30 am Breakfast, Exhibits Open

7:55 am Welcome Janice Kim, MD

Cosmetic Issues

8:00 am Case Christine Fang, MD

8:10 am Oncoplastics Ben Anderson, MD

8:30 am Breast Reconstruction Hakim Said, MD

8:50 am Lymphedema Janelle D Sousa, MD

9:10 am Panel All

Roger Moe Fellowship

9:30 am Introduction and award TBD

9:40 am Recipient presentation TBD

10:10 am Break

Survivorship

10:25 am Case Jennie R Crews, MD

10:35 am Breast cancer surveillance after becoming a survivor

John R Scheel, MD, PhD

10:55 am Complementary medicine issues – long term

Laura James, ND

11:15 am Role of physical therapy in post-treatment issues

Carol Baltaxe, PT, MPT, CLT

11:35 am Panel All

11:55 am-12:00 pm

Closing remarks; adjourn conference

Janice Kim, MD

Seattle Cancer Care Alliance brings together the leading research teams and cancer specialists of Fred Hutch, Seattle Children’s, and UW Medicine. One extraordinary group whose sole mission is the pursuit of better, longer, richer lives for our patients.

The American Lung Association’s LUNG FORCE initiative has partnered

with the Ad Council to launch the first national public service advertising

(PSA) campaign focused on lung cancer screening.

Saved by the Scan aims to raise awareness of the benefits of early

detection through lung cancer screening and drive individuals to take a

lung cancer screening eligibility quiz at SavedByTheScan.org so that the

approximately 9 million people in this country who are at high risk will

talk to their doctor about getting screened for lung cancer.

The Thoracic portion is co-presented by

American Lung Association’s LUNG FORCE

IF YOU SMOKED:This new lung cancer screening could save your life